Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 05:59:12 +0200Fri, 17 May 2024 14:54:00 +0200Human medicines European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde), irinotecan hydrochloride trihydrate, Date of authorisation: 14/10/2016, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/onivyde-pegylated-liposomal-previously-known-onivydeHuman medicines European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde), irinotecan hydrochloride trihydrate, Date of authorisation: 14/10/2016, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/onivyde-pegylated-liposomal-previously-known-onivydeFri, 17 May 2024 14:54:00 +0200Human medicineOnivyde : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500215171_en.pdfOnivyde : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500215171_en.pdfTue, 25 Oct 2016 17:29:00 +0200Human medicine